 |
 |
 |
 |
[ Source - CW , Dated - Aug 2009 ]
In its 50th year of operations, AFCONS, is a part of the Shapoorji Pallonji Group (SP Group), the third largest construction group in India with a group turnover in excess of Rs 90 billion. AFCONS has a presence in almost the entire spectrum of infrastructure activities in India and transnationally in the Middle East and Africa. It has executed over 150 marine structures covering the entire coastline of India, more than 100 bridges/flyovers, nearly 24 km of elevated metro corridors, two LNG storage tanks and over 2,500 lane km of roadwork. It is the first Indian construction company to have constructed an underground metro station (at Barakhamba Road, New Delhi) without a foreign JV and one of only four qualified bidders for construction of a nuclear power plant in the country. With ISO 9001:2000, ISO 14001:2004 and OHSAS 18001:1999 certification, AFCONS is also recognised by the Government of India as a 'Star Export House'. In March 2009, AFCONS got a total income of Rs 22.18 billion with a CAGR of 47 per cent over the past three years. Its goal is to achieve a turnover of $ 1 billion by 2011-12, of which 25 percent is from the overseas market. With an entry into the offshore oil and gas business, AFCONS has entered a different league. Accolades include the WQC International Star Award in the Gold category by Business Initiative Directions, Spain; safety awards from Reliance Industries Ltd. National Safety Council of India and Ishikawajima-Harima Heavy Industries Co. Ltd; and the ACCE FOSROC Award for effective use of construction chemicals in a civil engineering project by ACCE-I in 2001 for a tanker berth jetty trestle for RPL, Jamnagar. What's more, many projects constructed by AFCONS such as the Bandra-Worli Outfall Project, Mumbai; Airoli Bridge, Navi Mumbai; Mandovi Bridge, Goa; Sharavati Bridge, Honnavar; a railway bridge across Thane Creek in the Mankhurd-Belapur Railway Project-have been recognised for their excellence in construction and engineering.
Read an exclusive interview from Mr. K. Subrahmanian, MD on his views.
